Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
- 1 July 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 344 (8917) , 219-224
- https://doi.org/10.1016/s0140-6736(94)92996-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the Brit. Assoc. of Accident and Emergency Medicine, and the Brit. Paediatric Respiratory Group.Thorax, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthmaAllergy, 1989
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- A double‐blind dose‐response study of budesonide by inhalation in patients with bronchial asthmaAllergy, 1988
- DIFFERENCES IN HOSPITAL ASTHMA MANAGEMENTThe Lancet, 1988
- Controlled investigation of deaths from asthma in hospitals in the North East Thames region.BMJ, 1987
- Death from asthma in two regions of EnglandBMJ, 1982
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973